End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.2 TWD | -3.10% | -1.97% | -35.18% |
03-14 | Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-06 | Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer | CI |
- Stock Market
- Equities
- 6541 Stock
- News Tanvex BioPharma, Inc.